Trip or No Trip? The Diverging Development of Psychedelic Drugs for Mental Health (Subscription required) Adrienne Rivlin Read more
Executive Insights Digital Your AI Transformation Needs a Different Leadership Approach March 7, 2025
Article Life Sciences & Pharma AI and Biopharma: New Solutions Emerging Across the US Value Chain December 6, 2024
Special Report Life Sciences & Pharma Content Management Strategies for Pharmaceutical Companies Navigating Omnichannel… January 6, 2025
Podcast Life Sciences & Pharma A New Generation of Drug Therapies Requires New Business Strategies July 10, 2024
Article Mergers & Acquisitions Mergers and Acquisitions in Latin America: Evolution and Prospects May 13, 2024
Case Study Biotech and Pharmaceuticals Reimbursement Assessment for a Therapy for Hemodialysis Patients May 3, 2024 A biopharmaceutical company with a novel treatment of chronic kidney disease-associated pruritus asked L.E.K. to assess the potential risk of bundling of…
